Xencor Inc (XNCR)
Healthcare
Biotechnology
19.40 $
-4.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Xencor Inc (XNCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -68 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38 | -27 | 18 | -55 | -67 | -26 | -56 | -16 | -36 | -31 | -52 | -68 | -187 | |
| 2.9 | 3.1 | 3.2 | 3.0 | 3.0 | 3.1 | 3.0 | 2.7 | 2.7 | 2.6 | 2.6 | 2.6 | 10 | |
| 14 | 13 | 15 | 11 | 17 | 12 | 12 | 12 | 11 | 10 | 10 | 9.6 | 41 | |
| 14 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -20 | -26 | 53 | -15 | -20 | 24 | -14 | 25 | -6.1 | 20 | 8.1 | -2.9 | 19 | |
| 4.9 | 3.4 | 1.0 | 1.1 | 3.6 | 2.1 | 2.7 | 1.4 | 0.4 | 0.2 | 1.1 | 0.6 | 2.3 | |
| -1.4 | 45 | -203 | 32 | 66 | -163 | 57 | 12 | 40 | 15 | 71 | 27 | 153 | |
| 1.9 | – | 2.0 | – | – | 0.9 | 0.9 | – | 0.7 | 0.7 | 0.0 | – | – | |
| 1.9 | 0.4 | 186 | 0.2 | 1.1 | 188 | 10 | 3.0 | 0.7 | 0.0 | 6.3 | 1.0 | 7.9 | |
| -38 | 18 | 1.1 | -23 | -0.3 | -1.7 | 12 | -1.2 | 4.8 | -16 | 26 | -40 | -26 | |
| -43 | -31 | 17 | -56 | -71 | -28 | -58 | -18 | -37 | -31 | -53 | -68 | -189 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.